Polymorph Screening of the Antitumor Drug Ripretinib-Selective Preference of Dimer Synthons

Fayaz, TKS; Roy, P; Ghosh, A; Som, S; Chopra, D; Sanphui, P

Sanphui, P (通讯作者)，SRM Inst Sci & Technol, Fac Engn & Technol, Dept Chem, Chennai 603203, Tamil Nadu, India.

CRYSTAL GROWTH & DESIGN, 2023; 23 (4): 2470

Abstract

Ripretinib is commercialized as a medication to treat patients suffering from advanced gastrointestinal stromal tumor. The USFDA-approved drug (2020) ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索